| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $62.0M | -47.5% |
| SG&A Expense | $19.3M | -25.6% |
| Operating Income | -$83.5M | +42.0% |
| Income Tax | $0 | — |
| Net Income | -$61.8M | +55.4% |
| EPS (Basic) | -$1.18 | +69.2% |
| EPS (Diluted) | -$1.18 | +69.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.8M | -4.2% |
| Current Assets | $58.0M | -15.0% |
| Total Assets | $58.6M | -26.7% |
| Current Liabilities | $11.1M | -48.8% |
| Total Liabilities | $29.0M | +2.3% |
| Stockholders' Equity | $29.6M | -42.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.4M | +41.3% |
| Capital Expenditures | $362K | +0.0% |
| Investing Cash Flow | -$362K | +0.0% |
| Financing Cash Flow | $67.9M | +3971.0% |
| Free Cash Flow | -$70.7M | +41.2% |